Title of article
Reversible sideroblastic anemia associated with the tetracycline analogue COL-3
Author/Authors
Rudek، Michelle A. نويسنده , , Horne، McDonald نويسنده , , Figg، William D. نويسنده , , Dahut، William نويسنده , , Dyer، Valerie نويسنده , , Pluda، James M. نويسنده , , Reed، Eddie نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2001
Pages
-50
From page
51
To page
0
Abstract
Eight of 35 patients with cancer receiving COL-3, a tetracycline derivative with antiangiogenic properties, developed anemia while on treatment. All of these patients were enrolled on an approved Phase I clinical trial at the National Cancer Institute. Three of these patients had bone marrow examinations that revealed ringed sideroblasts. This paper describes these cases.
Keywords
neutropenic enterocolitis , typhlitis , acute leukemia
Journal title
American Journal of Hematology
Serial Year
2001
Journal title
American Journal of Hematology
Record number
25758
Link To Document